S'abonner

An Individual Participant Data Meta-analysis: Behavioral Treatments for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder - 20/01/22

Doi : 10.1016/j.jaac.2021.02.024 
Annabeth P. Groenman, PhD , Rianne Hornstra, MSc, Pieter J. Hoekstra, MD, PhD, Laura Steenhuis, PhD, Asma Aghebati, PhD, Bianca E. Boyer, PhD, Jan K. Buitelaar, MD, PhD, Andrea Chronis-Tuscano, PhD, David Daley, PhD, Parisa Dehkordian, MSc, Melissa Dvorsky, PhD, Nike Franke, PhD, George J. DuPaul, PhD, Naama Gershy, PhD, Elizabeth Harvey, PhD, Timo Hennig, DrPhil, Sharonne Herbert, PhD, Joshua Langberg, PhD, Jennifer A. Mautone, PhD, Amori Yee Mikami, PhD, Linda J. Pfiffner, PhD, Thomas J. Power, PhD, Sijmen A. Reijneveld, MD, PhD, Satyam Antonio Schramm, DrPhil, Julie B. Schweitzer, PhD, Margaret H. Sibley, PhD, Edmund Sonuga-Barke, PhD, Catharine Thompson, MSc, BSc, MBBS, Margaret Thompson, MBChB, MD, FRCPsy, FRCP, Carolyn Webster-Stratton, MSN, MPH, PhD, Yuhuan Xie, MD, PhD, Marjolein Luman, PhD *, Saskia van der Oord, PhD *, Barbara J. van den Hoofdakker, PhD *

Correspondence to Annabeth P. Groenman, PhD, Department of Child and Adolescent Psychiatry, Freepost 176, 9700 VB, Groningen, the NetherlandsDepartment of Child and Adolescent PsychiatryFreepost 176, 9700 VBGroningenthe Netherlands

Résumé

Objective

Behavioral interventions are well established treatments for children with attention-deficit/hyperactivity disorder (ADHD). However, insight into moderators of treatment outcome is limited.

Method

We conducted an individual participant data meta-analysis (IPDMA), including data of randomized controlled behavioral intervention trials for individuals with ADHD <18 years of age. Outcomes were symptoms of ADHD, oppositional defiant disorder (ODD), and conduct disorder (CD) and impairment. Moderators investigated were symptoms and impairment severity, medication use, age, IQ, sex, socioeconomic status, and single parenthood.

Results

For raters most proximal to treatment, small- to medium-sized effects of behavioral interventions were found for symptoms of ADHD, inattention, hyperactivity/impulsivity (HI), ODD and CD, and impairment. Blinded outcomes were available only for small preschool subsamples and limited measures. CD symptoms and/or diagnosis moderated outcome on ADHD, HI, ODD, and CD symptoms. Single parenthood moderated ODD outcome, and ADHD severity moderated impairment outcome. Higher baseline CD or ADHD symptoms, a CD diagnosis, and single parenthood were related to worsening of symptoms in the untreated but not in the treated group, indicating a protective rather than an ameliorative effect of behavioral interventions for these children.

Conclusion

Behavioral treatments are effective for reducing ADHD symptoms, behavioral problems, and impairment as reported by raters most proximal to treatment. Those who have severe CD or ADHD symptoms, a CD diagnosis, or are single parents should be prioritized for treatment, as they may evidence worsening of symptoms in the absence of intervention.

Le texte complet de cet article est disponible en PDF.

Key words : behavioral interventions, ADHD, individual participant data meta-analyses, moderator analyses


Plan


 Drs. Groenman, Steenhuis, Ms. Hornstra, Prof. Drs. Hoekstra and van den Hoofdakker are with the Center for Child and Adolescent Psychiatry, University of Groningen, University Medical Center, Groningen, The Netherlands. Dr. Groenman is also with the Dutch Autism and ADHD Research Center, University of Amsterdam, The Netherlands. Prof. Dr. Reijneveld is with University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Dr. Aghebati is with the School of Behavioral Sciences and Mental Health, Tehran Institute of Psychiatry, Iran University of Medical Sciences, Tehran, Iran. Dr. Boyer is with the University of Amsterdam, The Netherlands. Prof. Dr. Buitelaar is with the Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands, and Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, The Netherlands. Prof. Dr. Chronis-Tuscano is with the University of Maryland, College Park. Prof. Dr. Daley is with the School of Medicine, Institute of Mental Health, University of Nottingham, United Kingdom. Ms. Dehkordian is with Shahid Chamran University, Ahvaz, Iran. Drs. Dvorsky and Pfiffner are with the University of California San Francisco. Dr. Franke is with the Liggins Institute, University of Auckland, New Zealand. Dr. DuPaul is with Lehigh University, Bethlehem, Pennsylvania. Dr. Gershy is with the School of Education, Israel and Schneider Children's Medical Center, The Hebrew University of Jerusalem, Israel. Dr. Harvey is with the University of Massachusetts Amherst. Dr. Hennig is with Universität Hamburg, Germany. Dr. Herbert is with the Children's Hospital of Orange County, California. Prof. Dr. Langberg is with Virginia Commonwealth University, Richmond. Drs. Mautone and Power are with Children's Hospital of Philadelphia, Pennsylvania. Dr. Amori Yee Mikami is with the University of British Columbia, Vancouver, Canada. Prof. Dr. Schramm is with Inclusive Education, University of Potsdam, Germany. Dr. Schweitzer is with the University of California, Davis. Dr. Sibley is with the University of Washington School of Medicine, Seattle Children's Research Institute. Prof. Sonuga-Barke is with King's College London, United Kingdom. Ms. C. Thompson and Prof. Dr. M. Thompson are with the School of Psychology, University of Southampton, United Kingdom. Prof. Emeritus Webster-Stratton is with the University of Washington, Seattle. Dr. Xie is with the Specialty Mental Health Program of Asian Health Service, Oakland, California. Dr. Luman is with Vrije Universiteit Amsterdam, Amsterdam, The Netherlands, and Bascule, Academic Centre for Child and Adolescent Psychiatry, Amsterdam, The Netherlands. Prof. Dr. van der Oord is with Clinical Psychology, KU Leuven, Leuven, Belgium; and the University of Amsterdam, Amsterdam, the Netherlands.
 This research was funded by the Dutch Organization for Health Research and Development (ZonMw) under grant number 729300013 to Barbara J. van den Hoofdakker. The funder had no role in the design of this protocol, the collection of data, the data analysis, or the interpretation or publication of the study results.
 This work has been prospectively registered: display_record.php?RecordID=69877.
 Jos Twisk, PhD, of the Vrije Universteit Amsterdam, served as the statistical expert for this research.
 Author Contributions
Conceptualization: Groenman, Hoekstra, Steenhuis, Buitelaar, Reijneveld, Luman, van der Oord, van den Hoofdakker
Data curation: Groenman, Hornstra, Aghebati, Boyer, Chronis-Tuscano, Daley, Dehkordian, Dvorsky, Franke, DuPaul, Gershy, Harvey, Hennig, Herbert, Langberg, Mautone, Mikami, Pfiffner, Power, Schramm, Sibley, Sonuga-Barke, C. Thompson, M. Thompson, Webster-Stratton, Xie, Luman, van der Oord, van den Hoofdakker
Formal analysis: Groenman, van den Hoofdakker
Funding acquisition: Buitelaar, Reijneveld, Luman, van der Oord, van den Hoofdakker
Investigation: Groenman, Luman, van der Oord, van den Hoofdakker
Methodology: Groenman, Hoekstra, Luman, van der Oord, van den Hoofdakker
Project administration: Groenman
Resources: Hoekstra
Supervision: Luman, van der Oord, van den Hoofdakker
Visualization: Groenman, Hornstra
Writing – original draft: Groenman, Hornstra, Luman, van der Oord, van den Hoofdakker
Writing – review and editing: Groenman, Hornstra, Hoekstra, Steenhuis, Aghebati, Boyer, Buitelaar, Chronis-Tuscano, Daley, Dehkordian, Dvorsky, Franke, DuPaul, Gershy, Harvey, Hennig, Herbert, Langberg, Mautone, Mikami, Pfiffner, Power, Reijneveld, Schramm, Schweitzer, Sibley, Sonuga-Barke, C. Thompson, M. Thompson, Webster-Stratton, Xie, Luman, van der Oord, van den Hoofdakker.
 The authors would like to thank Jos Twisk, PhD, of the Vrije Universteit Amsterdam, for his advice regarding the analyses. Furthermore, the authors want to thank their research assistant Lieke Bruinsma, MSc, of the University of Groningen, University Medical Center Groningen, for her help in all types of administrative tasks that arose during this IPDMA.
 Disclosure: Prof. Dr. Hoekstra has attended a paid advisory board meeting of Shire (a Takeda Pharmaceutical Company). Dr. Boyer has co-developed Plan My Life and Solution Focused Treatment and has received royalties for both treatments. Prof. Dr. Buitelaar has been a consultant to / member of advisory board of / and/or speaker for Takeda/Shire, Roche, Medice, Angelini, Janssen, and Servier. He is not an employee of any of these companies and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, royalties in the past three years. Prof. Dr. Daley has reported grants, personal fees, and non-financial support from Shire/Takeda; personal fees and non-financial support from Medice and Eli Lilly and Co.; non-financial support from Qbtech; and book royalties from Jessica Kingsley from the self-help version of the New Forest Parenting Programme (NFPP). Drs. Harvey and Herbert have developed the Parenting Hyperactive Preschoolers program and have received royalties from the sale of the clinician workbook. Dr. Hennig has reported being one of the developers of the Lerntraining für Jugendliche mit ADHS (LeJA) and has received royalties from sales of the treatment manual. Prof. Dr. Langberg has developed the Homework, Organization, and Planning Skills (HOPS) intervention and has received royalties from sales of the treatment manuals. Dr. Power has received royalties from Guilford Press for a book, Homework Success for Children with ADHD, that describes many components incorporated into the Family-School Success investigations included in this study. Prof. Dr. Schramm has reported being one of the developers of the Lerntraining für Jugendliche mit ADHS (LeJA) and has received royalties from sales of the treatment manual. Dr. Sibley has received royalties from Guilford Press and Vimeo Inc. for intervention materials related to Supporting Teens’ Autonomy Daily (STAND). She has received consultancy fees from Takeda Pharmaceuticals. Prof. Sonuga-Barke was involved in the development of the NFPP for which he has received royalties. He has received consultancy, speaker fees, and conference attendance support variously from Shire, Neurotech Solutions, and Qbtech. Prof. Dr. Thompson has reported being a co-developer of the NFPP, data from trials has been included in this paper. She has received grants from the National Institute for Health Research (NIHR) to develop and evaluate this work. She has received training fees from training therapists in the program. Prof. Emer. Webster-Stratton has disclosed a potential conflict of interest due to the fact she is developer of one of the intervention programs (Incredible Years). Because she has provided training and instructional materials for these treatment programs, she stands to gain financially from a positive review. This interest has been disclosed to the university and has been managed consistent with federal and university policy regarding data management. Dr. Luman was involved in developing Positivity and Rules, a behavioral self-help teacher training, but has no financial interests. Prof. Dr. van der Oord has co-developed Plan My Life and Solution Focused Treatments and other behavioral treatments but has reported no financial interest in any of these. Prof. Dr. van den Hoofdakker has received research grants from ZonMw (The Netherlands Organisation for Health Research and Development), NWO (The Netherlands Organisation for Scientific Research), and UMCG (University Medical Centre Groningen) and royalties as one of the editors of “Sociaal Onhandig” (published by Van Gorcum), a Dutch book for parents of children with ADHD or PDD-NOS that is being used in parent training. She is and has been involved in the development and evaluation of several Dutch parent training programs, without financial interests; she is and has been a member of Dutch ADHD guideline groups and an advisor of the Dutch Knowledge Centre for Child and Adolescent Psychiatry. Ms. Thompson has received funding from NIHR to develop and evaluate an online version of the NFPP. She has received personal fees for helping with the training of the NFPP. Drs. Groenman, Steenhuis, Aghebati, Prof. Dr. Chronis-Tuscano, Drs. Dvorsky, Franke, DuPaul, Gershy, Mautone, Mikami, Pfiffner, Prof. Dr. Reijneveld, Drs. Schweitzer and Xie, and Mss. Hornstra and Dehkordian have reported no biomedical financial interests or potential conflicts of interest.


© 2021  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 61 - N° 2

P. 144-158 - février 2022 Retour au numéro
Article précédent Article précédent
  • Editorial: The Altered Brain Network Architecture of Anorexia Nervosa
  • Sylvane Desrivières
| Article suivant Article suivant
  • Systematic Review: Nonverbal Learning Disability
  • Prudence W. Fisher, Jazmin A. Reyes-Portillo, Mark A. Riddle, Hillary D. Litwin

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.